Rituximab for the treatment of acute onset Interstitial Lung Disease in primary Sjogren's syndrome
Guardado en:
Autores principales: | Giulia Klinowski, Filippo Gozzi, Fabiana Trentacosti, Dario Andrisani, Marco Sebastiani, Enrico M. Clini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier España
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/db9798d13dfd47f4948909893635952b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pulmonary vein stenosis mimicking interstitial lung disease
por: F. Carriço, et al.
Publicado: (2021) -
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)
por: R Gisli Jenkins, et al.
Publicado: (2021) -
The Extent of Honeycombing on Computed Tomography Cannot Predict the Treatment Outcome of Patients with Acute Exacerbations of Interstitial Lung Disease
por: Yurika Nishikawa, et al.
Publicado: (2021) -
In memoriam Claudio F. Donner
por: E. Clini
Publicado: (2021) -
Progressive fibrosing interstitial lung disease: prevalence and clinical outcome
por: Byoung Soo Kwon, et al.
Publicado: (2021)